We are live on
!
Find out more
UBS O'Connor Portfolio holdings
AUM
$3.76B
Turnover
54.76%
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+9.23%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.22B
AUM Growth
-$1.2B
(-22%)
Cap. Flow
-$1.32B
Cap. Flow
% of AUM
-31.23%
Top 10 Holdings %
Top 10 Hldgs %
40.53%
Holding
893
New
143
Increased
129
Reduced
82
Closed
273
Avg Time Held Equity + Options
0.9
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.2
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
OSH
Oak Street Health, Inc.
OSH
|
+$211M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$189M |
| 3 |
UNVR
Univar Solutions Inc.
UNVR
|
+$175M |
| 4 |
MAXR
Maxar Technologies Inc. Common Stock
MAXR
|
+$143M |
| 5 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STOR
STORE Capital Corporation
STOR
|
+$414M |
| 2 |
LHCG
LHC Group LLC
LHCG
|
+$211M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$196M |
| 4 |
SGFY
Signify Health, Inc.
SGFY
|
+$161M |
| 5 |
ONEM
1Life Healthcare
ONEM
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.21% |
| 2 | Healthcare | 21.3% |
| 3 | Technology | 18.64% |
| 4 | Miscellaneous | 15.12% |
| 5 | Industrials | 5.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
476
Vaxcyte
PCVX
$10.3B
| $303K | 0.01% |
8,071
+384
| +5% | +$16.3K |
2022 Q4
1 quarter
|
|
477
PUT
State Street Energy Select Sector SPDR ETF
XLE
$42.8B
| $297K | 0.01% |
+960,000
| New | +$41M |
2023 Q1
0 quarters
|
|
478
Pliant Therapeutics
PLRX
$60.2M
| $279K | 0.01% |
+10,500
| New | +$299K |
2023 Q1
0 quarters
|
|
479
Intel
INTC
$504B
| $278K | 0.01% |
+8,500
| New | +$241K |
2023 Q1
0 quarters
|
|
|
IPVI
480
DELISTED
InterPrivate IV InfraTech Partners Inc. Class A Common Stock
IPVI
| $267K | 0.01% |
25,878
-491,693
| -95% | -$5.03M |
2021 Q2
7 quarters
|
|
481
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $261K | 0.01% |
700,000
+400,000
| +133% | +$30M |
2022 Q3
2 quarters
|
|
482
Match Group
MTCH
$10.1B
| $259K | 0.01% |
+6,740
| New | +$294K |
2023 Q1
0 quarters
|
|
483
Acumen Pharmaceuticals
ABOS
$121M
| $249K | 0.01% |
61,358
+7,922
| +15% | +$41.4K |
2022 Q4
1 quarter
|
|
484
SAP
SAP
$260B
| $245K | 0.01% |
+1,937
| New | +$227K |
2023 Q1
0 quarters
|
|
485
PennyMac Financial
PFSI
$3.18B
| $241K | 0.01% |
4,035
-26,467
| -87% | -$1.64M |
2022 Q2
3 quarters
|
|
|
BKI
486
DELISTED
Black Knight, Inc. Common Stock
BKI
| $239K | 0.01% |
+4,160
| New | +$249K |
2023 Q1
0 quarters
|
|
487
Verastem
VSTM
$836M
| $235K | 0.01% |
47,227
| – | – |
2022 Q1
4 quarters
|
|
488
Bandwidth Inc
BAND
$1.6B
| $228K | 0.01% |
+15,000
| New | +$302K |
2023 Q1
0 quarters
|
|
489
PUT
US Global Jets ETF
JETS
$785M
| $221K | 0.01% |
+150,000
| New | +$2.9M |
2023 Q1
0 quarters
|
|
490
PUT
Medical Properties Trust
MPT
$1.86B
| $218K | 0.01% |
300,000
-500,000
| -63% | -$5.52M |
2022 Q4
1 quarter
|
|
491
PUT
United Airlines
UAL
$32.9B
| $214K | 0.01% |
350,000
-11,200
| -3% | -$537K |
2021 Q4
5 quarters
|
|
492
PUT
Norwegian Cruise Line
NCLH
$7.07B
| $210K | 0.01% |
55,100
-14,100
| -20% | -$211K |
2021 Q2
7 quarters
|
|
493
Tesla
TSLA
$1.43T
| $207K | ﹤0.01% |
1,000
-16,526
| -94% | -$2.88M |
2021 Q2
7 quarters
|
|
494
Bumble
BMBL
$783M
| $196K | ﹤0.01% |
+10,000
| New | +$226K |
2023 Q1
0 quarters
|
|
|
CPAAW
495
DELISTED
Conyers Park III Acquisition Corp. Warrants
CPAAW
| $190K | ﹤0.01% |
1,002,144
| – | – |
2021 Q4
5 quarters
|
|
496
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
| $180K | ﹤0.01% |
100,000
| – | – |
2022 Q3
2 quarters
|
|
497
Fulcrum Therapeutics
FULC
$280M
| $177K | ﹤0.01% |
+62,274
| New | +$558K |
2023 Q1
0 quarters
|
|
498
Hewlett Packard
HPE
$77.8B
| $175K | ﹤0.01% |
+10,997
| New | +$173K |
2023 Q1
0 quarters
|
|
499
CALL
BridgeBio Pharma
BBIO
$13.1B
| $174K | ﹤0.01% |
+89,300
| New | +$1.04M |
2023 Q1
0 quarters
|
|
500
PUT
Starwood Property Trust
STWD
$4.67B
| $170K | ﹤0.01% |
101,200
+30,100
| +42% | +$581K |
2021 Q2
7 quarters
|
|
Similar funds
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q1 2023 Portfolio in Review
As of Q1 2023, UBS O'Connor held 893 positions worth $4.22B, down 22% from $5.42B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
UBS O'Connor withdrew a net $1.32B in Q1 2023, closing 273 positions and reducing 82 holdings. Its most notable exit was STORE Capital Corporation, an estimated $414M position sold in full.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.
Against the trend, UBS O'Connor opened a new position in Oak Street Health, Inc. worth $25.3M.
- UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
- UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
- UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
- UBS O'Connor fully exited STORE Capital Corporation in Q1 2023, selling an estimated $414M.
- UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
- UBS O'Connor opened 143 new positions and closed 273 in Q1 2023.
- UBS O'Connor's portfolio value fell 22% quarter-over-quarter to $4.22B.
Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.